AAA April 2011

Oxford Nanopore fits in $41m

Oxford Nanopore Technologies, a UK-based developer of human genome technology, has raised £25m ($41m) from a consortium including its DNA sequencing marketing partner, Illumina UK. The other investors in Oxford Nanopore, which is valued in the round at £155m, included hedge fund Lansdowne Partners, London-listed developer of intellectual property-based businesses IP Group, mutual fund manager… Continue reading Oxford Nanopore fits in $41m